Biggest change(Dollars in thousands) Years ended December 31: 2024 2023 Net income $ 15,503 $ 37,382 Depreciation 9,208 10,348 Non-cash stock-based compensation 359 - Interest and dividend income (7,656 ) (9,577 ) Non-cash interest expense and amortization of deferred financing costs 138 135 Loss on disposal of property and equipment 30 29 Unrealized loss (gain) on derivative instruments 1,971 (1,878 ) Gain on marketable securities - (575 ) Other income (2,751 ) (882 ) Income tax provision 792 1 Adjusted EBITDA $ 17,594 $ 34,983 The following table reconciles adjusted EBITDA with cash flows from operations, the most directly comparable GAAP liquidity financial measure: (Dollars in thousands) Years ended December 31: 2024 2023 Net cash provided by operating activities $ 24,802 $ 21,299 Provision for deferred income taxes (773 ) - Interest and dividend income (7,656 ) (9,577 ) Income tax provision 792 1 Changes in operating assets and liabilities, net 3,180 24,143 Other non-operating income (2,751 ) (883 ) Adjusted EBITDA $ 17,594 $ 34,983 36 Table of Contents Results of Operations Consolidated 2024 Compared to 2023: 2023 Compared to 2022: Change Change (Dollars in thousands) 2024 2023 $ % 2023 2022 $ % Sales $ 243,339 $ 368,250 $ (124,911 ) (34 %) $ 368,250 $ 396,014 $ (27,764 ) (7 %) Volume/product mix effect $ (59,546 ) (16 %) $ 45,350 11 % Price effect $ (65,365 ) (18 %) $ (73,114 ) (18 %) Gross profit $ 19,644 $ 40,979 $ (21,335 ) (52 %) $ 40,979 $ 28,993 $ 11,986 41 % Operating expense $ 13,272 $ 13,611 $ (339 ) (2 %) $ 13,611 $ 11,447 $ 2,164 19 % Other (income) expense $ (9,923 ) $ (10,015 ) $ 92 1 % $ (10,015 ) $ 3,808 $ (13,823 ) NA Pretax income $ 16,295 $ 37,383 $ (21,088 ) (56 %) $ 37,383 $ 13,738 $ 23,645 172 % Income tax provision (benefit) $ 792 $ 1 $ 791 79100 % $ 1 $ (1,473 ) $ 1,474 NA Net income $ 15,503 $ 37,382 $ (21,879 ) (59 %) $ 37,382 $ 15,211 $ 22,171 146 % 2024 Compared to 2023 Consolidated sales revenue decreased 34% or $124,911 in 2024 compared to 2023 from lower sales volumes ($60,574) and lower prices ($65,011) in the biofuel segment.
Biggest change(Dollars in thousands) Years ended December 31: 2025 2024 Net (loss) income $ (49,397 ) $ 15,503 Depreciation 9,657 9,208 Non-cash stock-based compensation 1,008 359 Interest income, net (3,758 ) (7,656 ) Non-cash interest expense and amortization of deferred financing costs 118 138 (Gain) loss on disposal of property and equipment (34 ) 30 Unrealized (gain) loss on derivative instruments (221 ) 1,971 Turnaround costs 3,801 3,723 Other loss (income) 344 (2,751 ) Income tax provision 165 792 Adjusted EBITDA $ (38,317 ) $ 21,317 The following table reconciles adjusted EBITDA with cash flows from operations, the most directly comparable GAAP liquidity financial measure: (Dollars in thousands) Years ended December 31: 2025 2024 Net cash (used in) provided by operating activities $ (28,735 ) $ 24,802 Provision for deferred income taxes (137 ) (773 ) Interest income, net (3,758 ) (7,656 ) Income tax provision 165 792 Changes in operating assets and liabilities, net (9,997 ) 3,180 Turnaround costs 3,801 3,723 Other non-operating (loss) income 344 (2,751 ) Adjusted EBITDA $ (38,317 ) $ 21,317 36 Table of Contents Results of Operations Consolidated 2025 Compared to 2024: Change (Dollars in thousands) 2025 2024 $ % Sales $ 95,742 $ 243,339 $ (147,597 ) (61% ) Volume/product mix effect $ (137,218 ) (56 )% Price effect $ (10,379 ) (4 )% Gross (loss) profit $ (39,425 ) $ 19,644 $ (59,069 ) NA Operating expense $ 13,565 $ 13,272 $ 293 2 % Other (income) expense $ (3,758 ) $ (9,923 ) $ 6,165 62 % Pretax (loss) income $ (49,232 ) $ 16,295 $ (65,527 ) NA Income tax provision (benefit) $ 165 $ 792 $ (627 ) (79% ) Net (loss) income $ (49,397 ) $ 15,503 $ (64,900 ) NA 2025 Compared to 2024 For the fiscal year ended December 31, 2025, consolidated revenue decreased 61% ($147,597) compared to 2024.
Cost of goods sold is allocated to the chemicals and biofuels business segments based on equipment and resource usage for most conversion costs and based on revenue for most other costs. Operating costs include selling, general and administrative, and research and development expenses.
Cost of goods sold is allocated to the Chemicals and Biofuels segments based on equipment and resource usage for most conversion costs and based on revenue for most other costs. Operating costs include selling, general and administrative, and research and development expenses.
The discussion of results of operations that follows is based on revenue and expenses in total and for individual product lines and does not differentiate related party transactions. 34 Table of Contents Fiscal Year Ended December 31, 2024 Compared to Fiscal Year Ended December 31, 2023 Set forth below is a summary of certain financial information for the periods indicated.
The discussion of results of operations that follows is based on revenue and expenses in total and for individual product lines and does not differentiate related party transactions. 34 Table of Contents Fiscal Year Ended December 31, 2025 Compared to Fiscal Year Ended December 31, 2024 Set forth below is a summary of certain financial information for the periods indicated.
Revenue from bill-and-hold transactions in which a performance obligation exists is recognized when the total performance obligation has been met and control of the product has transferred. Bill-and-hold transactions for 2024 and 2023 were related to custom chemicals customers whereby revenue was recognized in accordance with contractual agreements based upon product being produced and ready for use by the customer.
Revenue from bill-and-hold transactions in which a performance obligation exists is recognized when the total performance obligation has been met and control of the product has transferred. Bill-and-hold transactions for 2025 and 2024 were related to custom chemicals customers whereby revenue was recognized in accordance with contractual agreements based upon product being produced and ready for use by the customer.
These hedging transactions are recognized in earnings and do not qualify as a hedge accounting treatment on our consolidated balance sheets at December 31, 2024 or 2023, as they do not meet the definition of a hedge instrument as defined under GAAP. The purchase of biofuels feedstock generally involves two components: basis and price.
These hedging transactions are recognized in earnings and do not qualify as a hedge accounting treatment on our consolidated balance sheets at December 31, 2025 or 2024, as they do not meet the definition of a hedge instrument as defined under GAAP. The purchase of biofuels feedstock generally involves two components: basis and price.
We are liable for these asset retirement obligations and environmental contingencies only in certain events, primarily the closure of our Batesville, Arkansas facility. As such, we do not expect a payment related to these liabilities in the foreseeable future and therefore we have excluded this amount from the table above. 44 Table of Contents
We are liable for these asset retirement obligations and environmental contingencies only in certain events, primarily the closure of our Batesville, Arkansas facility. As such, we do not expect a payment related to these liabilities in the foreseeable future and therefore we have excluded this amount from the table above. 45 Table of Contents
This activity was captured on our consolidated balance sheets at December 31, 2024 and 2023. Second, we hedge our biofuels feedstock through the execution of purchase contracts and supply agreements with certain vendors which meet the normal purchase and normal sales exception of ASC 815 Derivatives and Hedging .
This activity was captured on our consolidated balance sheets at December 31, 2025 and 2024. Second, we hedge our biofuels feedstock through the execution of purchase contracts and supply agreements with certain vendors which meet the normal purchase and normal sales exception of ASC 815 Derivatives and Hedging .
The Credit Agreement consists of a five-year revolving credit facility in a dollar amount of up to $75,000, which includes a sublimit of $30,000 for letters of credit and $15,000 for swingline loans (collectively, the “Credit Facility”). The Credit Facility expires on February 21, 2030.
The Credit Agreement consists of a five-year revolving credit facility in a dollar amount of up to $35,000, which includes a sublimit of $30,000 for letters of credit and $15,000 for swingline loans (collectively, the “Credit Facility”). The Credit Facility expires on February 21, 2030.
Pricing for the other performance chemical products is established based upon competitive market conditions. Some, but not all, of these products have pricing mechanisms and/or specific protections against raw material or conversion cost changes. 33 Table of Contents For our biofuels segment, we procure all of our own feedstock and only sell biodiesel for our own account.
Pricing for the other performance chemical products is established based upon competitive market conditions. Some, but not all, of these products have pricing mechanisms and/or specific protections against raw material or conversion cost changes. For our biofuels segment, we procure all of our own feedstock and only sell biodiesel for our own account.
Liquidity and Capital Resources Our net cash provided by (used in) operating activities, investing activities, and financing activities for the years ended December 31, 2024, 2023 and 2022 are set forth in the following table.
Liquidity and Capital Resources Our net cash provided by (used in) operating activities, investing activities, and financing activities for the years ended December 31, 2025, 2024 and 2023 are set forth in the following table.
As of December 31, 2024, approximately 83% o f these deposits were insured by the Federal Deposit Insurance Corporation. Off-Balance Sheet Arrangements We engage in two types of hedging transactions. First, we hedge our biofuels sales through the purchase and sale of futures contracts and options on futures contracts of energy commodities.
As of December 31, 2025, approximately 89% o f these deposits were insured by the Federal Deposit Insurance Corporation. Off-Balance Sheet Arrangements We engage in two types of hedging transactions. First, we hedge our biofuels sales through the purchase and sale of futures contracts and options on futures contracts of energy commodities.
Historically, we finance capital requirements for our business with cash flows from operations and have not had the need to incur bank indebtedness to finance any of our operations during the periods discussed herein. 42 Table of Contents Credit Facility On February 21, 2025, the Company, with FutureFuel Chemical Company as the borrower and certain of the Company’s other subsidiaries as guarantors, amended and restated its credit agreement (the “Credit Agreement”) originally entered into on April 16, 2015 with the lenders party thereto, Regions Bank as administrative agent and collateral agent, and PNC Bank, N.A., as syndication agent and further amended on March 30, 2020 (as amended, the “Prior Credit Agreement”).
Historically, we finance capital requirements for our business with cash flows from operations and have not had the need to incur bank indebtedness to finance any of our operations during the periods discussed herein. 43 Table of Contents Credit Facility On February 21, 2025, the Company, with FutureFuel Chemical Company as the borrower and certain of the Company’s other subsidiaries as guarantors, amended and restated its credit agreement, as further amended effective as of June 30, 2025 and December 22, 2025 (the “Credit Agreement”), originally entered into on April 16, 2015 with the lenders party thereto, Regions Bank as administrative agent and collateral agent, and PNC Bank, N.A., as syndication agent (as amended, the “Prior Credit Agreement”).
As of December 31, 2024, based on all available and allowable evidence, the Company determined that its deferred tax assets of $41,076 are more likely than not realizable only to the extent of $18,691, resulting in a net deferred tax liability of $773.
As of December 31, 2024, based on all available and allowable evidence, the Company determined that its deferred tax assets were more likely than not realizable only to the extent of $18,691, resulting in a net deferred tax liability of $773.
In 2022, we paid regular cash dividends aggregating $0.24 per share on our common stock with record dates and payment dates as previously discussed. The regular cash dividends declared in 2022 totaled $21,006; $10,503 paid in 2022 and $10,503 paid in 2023. 43 Table of Contents Capital Management As a result of positive operating results, we accumulated excess working capital.
In 2023, we paid regular cash dividends aggregating $0.24 per share on our common stock with record dates and payment dates as previously discussed. The regular cash dividends declared in 2023 totaled $10,503 to be paid in 2024. 44 Table of Contents Capital Management As a result of historical positive operating results, we accumulated excess working capital.
Sales revenue under bill-and-hold arrangements were $43,959, $43,766, and $36,805 for the years ended December 31, 2024, 2023 and 2022, respectively. At December 31, 2024 and 2023, $7,301 and $4,317, respectively, was included in revenue for products that had not shipped.
Sales revenue under bill-and-hold arrangements were $36,690, $43,959, and $43,766 for the years ended December 31, 2025, 2024 and 2023, respectively. At December 31, 2025 and 2024, $5,147 and $7,301, respectively, was included in revenue for products that had not shipped.
We have the capability to process multiple types of feedstocks including vegetable oils, animal fats, and separated food waste oils. We can receive feedstock by rail or truck, and we have substantial storage capacity to acquire feedstock at advantaged prices when market conditions permit. Our annual biodiesel production capacity is 59 million gallons per year.
We have the capability to process multiple types of feedstocks including vegetable oils, animal fats, and separated food waste oils. We can receive feedstock by rail or truck, and we have substantial storage capacity to acquire feedstock at advantaged prices when market conditions permit.
Item 7. Management ’ s Discussion and Analysis of Financial Condition and Results of Operations. The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read together with our consolidated financial statements, including the Notes thereto, set forth herein.
Item 7. Management ’ s Discussion and Analysis of Financial Condition and Results of Operations. The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read together with our consolidated financial statements, including the Notes thereto, set forth herein. Further, for additional discussion of our results for 2024, compared to 2023, please see “Item 7.
Contractual Obligations Purchase obligations include the purchase of biodiesel feedstock and various other infrastructure and capital repairs as follows: Less than 1 year $ 9,420 1-3 years 418 4-5 years 137 Total $ 9,975 A component of other noncurrent liabilities is a reserve for asset retirement obligations and environmental contingencies of $1,466 at December 31, 2024.
Contractual Obligations Purchase obligations include the purchase of biodiesel feedstock and various other infrastructure and capital repairs as follows: Less than 1 year $ 11,029 1-3 years 412 4-5 years - Total $ 11,441 A component of other noncurrent liabilities is a reserve for asset retirement obligations and environmental contingencies of $1,503 at December 31, 2025.
The Company’s effective tax rate for 2024 and 2023 includes an expense of $8,169 or 50.1% and $6,821 or 18.2%, respectively, from the recording of a valuation allowance against its deferred tax assets.
The Company’s effective tax rate for 2025 and 2024 includes an expense of $11,558 or 23.5% and $8,169 or 50.1%, respectively, from the recording of a valuation allowance against its deferred tax assets.
All Foreign Period United States Countries Total Year ended December 31, 2024 $ 242,685 $ 654 $ 243,339 Year ended December 31, 2023 $ 367,368 $ 882 $ 368,250 Year ended December 31, 2022 $ 394,671 $ 1,343 $ 396,014 The majority of our expenses are cost of goods sold.
All Foreign Period United States Countries Total Year ended December 31, 2025 $ 94,790 $ 952 $ 95,742 Year ended December 31, 2024 $ 242,685 $ 654 $ 243,339 Year ended December 31, 2023 $ 367,368 $ 882 $ 368,250 The majority of our expenses are cost of goods sold.
The majority of our revenue is from short-term contracts with revenue recognized when a single performance obligation to transfer product under the terms of a contract with a customer is satisfied.
We sell to customers through master sales agreements or standalone purchase orders. The majority of our revenue is from short-term contracts with revenue recognized when a single performance obligation to transfer product under the terms of a contract with a customer is satisfied.
Dividends In 2024, we paid regular cash dividends aggregating $0.24 per share on our common stock with record dates and payment dates as previously discussed. The regular cash dividends declared in 2024 totaled $10,513 to be paid in 2025. On March 12, 2024, we also declared a special cash dividend of $2.50 per share on our common stock.
Dividends In 2025, we paid regular cash dividends aggregating $0.24 per share on our common stock with record dates and payment dates as previously discussed. The regular cash dividends declared in 2025 totaled $2,681 to be paid in the first quarter of 2026.
The latter amounts do not include Contract Assets of $29 and $734 that have not been billed nor shipped at December 31, 2024 and 2023, respectively. Taxes collected from customers and remitted to governmental authorities are recorded on a net basis within cost of goods sold.
The latter amounts do not include Contract Assets of $ 40 and $29 that have not been billed nor shipped at December 31, 2025 and 2024, respectively. Taxes collected from customers remitted to governmental authorities are recorded as a reduction of the transaction price.
Shipping and handling fees related to sales transactions were billed to customers and recorded as sales revenue. Income Taxes The provision for (benefit from) income taxes is determined using the asset and liability approach of accounting for income taxes.
Shipping and handling fees related to sales transactions are billed to customers and recorded as sales revenue with an offsetting expense included in cost of goods sold. 41 Table of Contents Income Taxes The provision for (benefit from) income taxes is determined using the asset and liability approach of accounting for income taxes.
As of December 31, 2023, based on all available and allowable evidence, the Company determined that its deferred tax assets are more likely than not realizable only to the extent of its deferred tax liabilities and recorded the resulting valuation allowance.
As of December 31, 2025, based on all available and allowable evidence, the Company determined that its deferred tax assets of $53,400 are more likely than not realizable only to the extent of $19,484, resulting in a net deferred tax liability of $910.
The Company recognizes income tax positions that meet the more likely than not threshold and accrues interest related to unrecognized income tax positions which is recorded as a component of the income tax provision.
The Company recognizes income tax positions only when they meet the more likely than not threshold. The Company's policy is to record interest and penalties related to unrecognized benefits as a component of the income tax provision in the Consolidated Statement of Income and Comprehensive Income.
This special dividend paid on April 9, 2024 amounted to $109,408. Total cash dividends paid in 2024 were $119,911 . In 2023, we paid regular cash dividends aggregating $0.24 per share on our common stock with record dates and payment dates as previously discussed. The regular cash dividends declared in 2023 totaled $10,503 to be paid in 2024.
The regular cash dividends declared in 2024 totaled $10,513 to be paid in 2025. On March 12, 2024, we also declared a special cash dividend of $2.50 per share on our common stock. This special dividend paid on April 9, 2024 amounted to $109,408. Total cash dividends paid in 2024 were $119,911 .
This decrease was primarily attributable to the sale of marketable securities in 2023 of $37,701. In addition, increased capital expenditures decreased cash from investing activities by $8,646. Cash provided by investing activities was $33,022 in 2023 compared to cash used by investing activities of $3,829 in 2022 for a net increase in cash of $36,851.
This decrease was primarily attributable to the sale of marketable securities in 2023 of $37,701. In addition, increased capital expenditures decreased cash from investing activities by $8,646. Financing Activities Cash used in financing activities was $10,889 in 2025, primarily from the payment of dividends of $10,513.
Partially offsetting the increase in cash from operations was the decrease of $21,879 in net income in 2024 compared to 2023 and the change in deferred revenue of $6,787 and other non-current liabilities of $3,317. Cash provided by operating activities decreased in 2023 to $21,299 from $52,451 in 2022, a net decrease of $31,152.
Partially offsetting the increase in cash from operations was the decrease of $21,879 in net income in 2025 compared to 2024 and the change in deferred revenue of $6,787 and other non-current liabilities of $3,317. 42 Table of Contents Investing Activities Cash used in investing activities was $18,601 in 2025 compared to $14,794 in 2024 for a net decrease in cash of $3,807.
The primary amendment from the Prior Credit Agreement was a reduction in the facility’s credit limit by $25,000. We will be permitted to use net proceeds of any borrowings under the Credit Facility for working capital and other general corporate purposes. No borrowings were made under the Prior Credit Agreement as of December 31, 2024 and 2023.
We will be permitted to use net proceeds of any borrowings under the Credit Facility for working capital and other general corporate purposes. No borrowings were made under the Prior Credit Agreement as of December 31, 2025 and 2024. See Note 12 of the consolidated financial statements for additional information regarding our Credit Agreement.
(Dollars in thousands other than per share amounts) Year Year Ended Ended December 31, December 31, Dollar % 2024 2023 Change Change Revenue $ 243,339 $ 368,250 $ (124,911 ) (34 )% Income from operations $ 6,372 $ 27,368 $ (20,996 ) (77 )% Net income $ 15,503 $ 37,382 $ (21,879 ) (59 )% Earnings per common share: Basic $ 0.35 $ 0.85 $ (0.50 ) (59 )% Diluted $ 0.35 $ 0.85 $ (0.50 ) (59 )% Adjusted EBITDA $ 17,594 $ 34,983 $ (17,389 ) (50 )% We use adjusted EBITDA as a key operating metric to measure both performance and liquidity.
(Dollars in thousands other than per share amounts) Year Year Ended Ended December 31, December 31, Dollar % 2025 2024 Change Change Revenue $ 95,742 $ 243,339 $ (147,597 ) (61 )% (Loss) income from operations $ (52,990 ) $ 6,372 $ (59,362 ) NA Net (loss) income $ (49,397 ) $ 15,503 $ (64,900 ) NA (Loss) earnings per common share: Basic $ (1.13 ) $ 0.35 $ (1.48 ) NA Diluted $ (1.13 ) $ 0.35 $ (1.48 ) NA Adjusted EBITDA $ (38,317 ) $ 21,317 $ (59,634 ) NA We use adjusted EBITDA as a key operating metric to measure both performance and liquidity.
(Dollars in thousands) 2024 2023 2022 Net cash provided by operating activities $ 24,802 $ 21,299 $ 52,451 Net cash (used in) provided by investing activities $ (14,794 ) $ 33,022 $ (3,829 ) Net cash used in financing activities $ (119,911 ) $ (10,517 ) $ (10,503 ) 41 Table of Contents Operating Activities Cash provided by operating activities increased in 2024 to $24,802 from $21,299 in 2023, a net increase of $3,503.
(Dollars in thousands) 2025 2024 2023 Net cash (used in) provided by operating activities $ (28,735 ) $ 24,802 $ 21,299 Net cash (used in) provided by investing activities $ (18,601 ) $ (14,794 ) $ 33,022 Net cash used in financing activities $ (10,889 ) $ (119,911 ) $ (10,517 ) Operating Activities Cash used in operating activities was $28,735 in 2025 compared to cash provided by operating activities of $24,802 in 2024, a net decrease in cash of $53,537 primarily attributed to a decrease of $64,900 in net income from 2025 to 2024.
Based on technical guidance from the Internal Revenue Service, the Company excludes the portion of the BTC not used to satisfy excise tax liabilities from income. See Note 3 to our consolidated financial statements for a discussion of the pretax earnings impact of the BTC.
Based on technical guidance from the Internal Revenue Service, the Company excluded the portion of the BTC not used to satisfy excise tax liabilities from its taxable income, impacting the effective tax rate.
Partially offsetting the decrease in cash from operations was the increase of $22,171 in net income in 2023 compared to 2022. Investing Activities Cash used in investing activities was $14,794 in 2024 compared to cash provided by investing activities of $33,022 in 2023 for a net decrease in cash of $47,816.
This decrease in cash was primarily attributable to increased capital expenditures of $2,579 and the change in the collateralization of derivative instruments of $1,256. Cash used in investing activities was $14,794 in 2024 compared to cash provided by investing activities of $33,022 in 2023 for a net decrease in cash of $47,816.
In addition, we deliver blended product to a small group of customers within our region. We also sell D4 and D6 RINs from time to time. At December 31, 2024 we held 3.1 million RINs with a market value of $1,831 and at December 31, 2023, we held 4.3 million RINs in inventory with a market value of $6,567.
We have both truck and rail access at our Batesville facility. In addition, we deliver blended product to a small group of customers within our region, and from time to time, sell D4 and D6 RINs.
While biodiesel is the principal component of the biofuels segment, we also generate revenue from the sale of petrodiesel both in blends with our biodiesel and, from time to time, with no biodiesel added. Petrodiesel and biodiesel blends are available to customers at our leased storage facility in North Little Rock, Arkansas and at our Batesville plant.
For a detailed analysis of these variables, please refer to "Risk Factors" and Note 3 of our consolidated financial statements. While biodiesel is the principal component of the biofuels segment, we also generate revenue from the sale of petrodiesel both in blends with our biodiesel and, from time to time, with no biodiesel added.
Most of our sales are FOB the Batesville plant, although some transfer points are in other states or foreign ports.
At December 31, 2025, we held 0.4 million RINs with a market value of $379 and at December 31, 2024, we held 3.1 million RINs in inventory with a market value of $1,831. Most of our sales are FOB the Batesville plant, although some transfer points are in other states or foreign ports.
The Company’s unrecognized tax benefit totaled $0 at December 31, 2023 and 2022. 38 Table of Contents Chemicals Segment 2024 Compared to 2023: 2023 Compared to 2022: Change Change (Dollars in thousands) 2024 2023 $ % 2023 2022 $ % Sales $ 80,007 $ 79,333 $ 674 0.8 % $ 79,333 $ 80,893 $ (1,560 ) (1.9 %) Volume/product mix effect 1,028 1.3 % 356 0.4 % Price effect (354 ) (0.4 %) (1,916 ) (2.4 %) Gross profit $ 22,632 $ 29,936 $ (7,304 ) (24.4 %) $ 29,936 $ 25,645 $ 4,291 16.7 % 2024 Compared to 2023 Chemical sales revenue increased 1% or $674 in 2024 compared with 2023.
The Company’s unrecognized tax benefit totaled $0 at December 31, 2025 and 2024. 38 Table of Contents Chemicals Segment 2025 Compared to 2024: Change (Dollars in thousands) 2025 2024 $ % Sales $ 59,565 $ 80,007 $ (20,442 ) (25.6 )% Volume/product mix effect (14,382 ) (18.0 )% Price effect (6,060 ) (7.6 )% Gross (loss) profit $ (13,007 ) $ 22,632 $ (35,639 ) NA 2025 Compared to 2024 For the fiscal year 2025, chemical sales revenue totaled $59,565, a 26% ($20,442) contraction compared to 2024.
Depreciation is provided for using the straight-line method over the associated asset’s estimated useful lives. 40 Table of Contents Revenue Recognition We recognize revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers , when performance obligations of the customer contract are satisfied. We sell to customers through master sales agreements or standalone purchase orders.
Changes in estimates are accounted for prospectively, meaning any adjustments to useful lives will impact depreciation expense in the current and future periods. Revenue Recognition We recognize revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers , when performance obligations of the customer contract are satisfied.
Biofuels gross profit decreased $14,031 in 2024 compared to 2023.
Gross profit for the Biofuels segment decreased by $23,430 in 2025 compared to 2024.
In 2022, the liquidation effect of exiting the pipeline business increased gross profit $1,851 in 2022; no such liquidation occurred in 2023. Critical Accounting Policies and Estimates Useful Lives of Property, Plant, and Equipment We primarily base our estimate of an asset’s useful life on our experience with other similar assets.
Critical Accounting Policies and Estimates Useful Lives of Property, Plant, and Equipment The determination of an asset's useful life is a fundamental estimate that impacts our financial results. We primarily establish these estimates based on historical experience with similar assets.
Capital Expenditure Commitments We had $1,460 of ne w chemical production equipment and infrastructure capital repair projects that generated commitments as of December 31, 2024. We plan to continue to invest in capital infrastructure to increase the reliability of plant operations.
Cash used in financing activities was $119,911 in 2024, primarily from the payment of a special cash dividend of $109,408 in addition to regular cash dividends. Capital Expenditure Commitments We had $4,302 of ne w chemical production equipment and infrastructure capital repair projects that generated commitments as of December 31, 2025.
Income tax provision (benefit) The income tax provision was $1 in 2023 or an effective tax rate of 0.0% as compared to a benefit in 2022 of ($1,473) or an effective tax rate of (10.7%).
Income tax provision The income tax provision was $165 in 2025 or an effective tax rate of (0.3%) as compared to a provision in 2024 of $792 or an effective tax rate of 4.9%. The Company's effective tax rate for the years 2025 and 2024 reflects the effect of certain tax credits and incentives.
These reductions were mostly offset by the receipt of a $2,750 settlement in 2024 (see Note 22 of our consolidated financial statements for further details). Income tax provision (benefit) The income tax provision was $792 in 2024 or an effective tax rate of 4.9% as compared to a provision in 2023 of $1 or an effective tax rate of 0.0%.
This increase was primarily the result of increased executive compensation expense. Other income decreased $6,165 in 2025 as compared to 2024. This net decrease was due to (i) the reduction of interest income of $3,745, and (ii) the prior year receipt of a $2,750 settlement in 2024 (see Note 22 of our consolidated financial statements for further details).
Financing Activities Cash used in financing activities increased to $119,911 in 2024 from $10,517 in 2023, a net increase of $109,394 primarily from the payment of a special cash dividend of $109,408. Cash used in financing activities was $10,517 in 2023, primarily from the payment of dividends of $10,503.
Cash provided by operating activities increased in 2024 to $24,802 from $21,299 in 2023, a net increase of $3,503.